View Post Adenovirus Vectors As HIV-1 Vaccines: Where are We? What Next? AIDS, 29(4): 395-400. In by AHFNovember 1, 2014
View Post Engineering the Human Thymic Microenvironment to Support Thymopoiesis In Vivo. Stem Cells, 32: 2386-2396. In by AHFSeptember 15, 2014
View Post Ineffectual Targeting of HIV-1 Nef by Cytotoxic T Lymphocytes in Acute Infection Results in No Functional Impairment or Viremia Reduction. Journal of Virology, 88(14): 7881-7892. In by AHFJuly 15, 2014
View Post Home-Based HIV Testing for Men Who Have Sex with Men in China: A Novel Community-Based Partnership to Complement Government Programs. PLOS ONE, 9(7): 1-7. In by AHFJuly 1, 2014
View Post Modeling Scenarios for the End of AIDS. Clinical Infectious Diseases, 59(Suppl. 1): S16-S20. In by AHFJuly 1, 2014
View Post Linkage to Care Following Community-Based Mobile HIV Testing Compared with Clinic-Based Testing in Umlazi Township, Durban, South Africa. HIV Medicine, 15: 367-372. In by AHFJuly 1, 2014
View Post HIV-1 Quasispecies Delineation by Tag Linkage Deep Sequencing. PLOS ONE, 9(50): 1-10. In by AHFMay 15, 2014
View Post Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial. PLOS ONE, 9(5): 1-10. In by AHFMay 15, 2014
View Post Differential Blood and Mucosal Immune Responses Against an HIV-1 Vaccine Administered Via Inguinal or Deltoid Injection. PLOS ONE, 9(2): 1-11. In by AHFFebruary 15, 2014
View Post Predictors of Serological Failure after Treatment in HIV-Infected Patients with Early Syphilis in the Emerging Era of Universal Antiretroviral Therapy Use. BMC Infectious Diseases, 13: 1-6. In by AHFDecember 1, 2013
